Try our beta test site

A Study of the Effect of Dalcetrapib on Artherosclerotic Disease in Patients With Coronary Artery Disease

This study has been terminated.
(Termination of the clinical development program by the Sponsor)
Information provided by (Responsible Party):
Hoffmann-La Roche Identifier:
First received: January 29, 2010
Last updated: August 8, 2016
Last verified: August 2016